Correlation Between Polydex Pharmaceuticals and Galapagos

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Polydex Pharmaceuticals and Galapagos at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Polydex Pharmaceuticals and Galapagos into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Polydex Pharmaceuticals and Galapagos NV ADR, you can compare the effects of market volatilities on Polydex Pharmaceuticals and Galapagos and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Polydex Pharmaceuticals with a short position of Galapagos. Check out your portfolio center. Please also check ongoing floating volatility patterns of Polydex Pharmaceuticals and Galapagos.

Diversification Opportunities for Polydex Pharmaceuticals and Galapagos

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Polydex and Galapagos is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Polydex Pharmaceuticals and Galapagos NV ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Galapagos NV ADR and Polydex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Polydex Pharmaceuticals are associated (or correlated) with Galapagos. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Galapagos NV ADR has no effect on the direction of Polydex Pharmaceuticals i.e., Polydex Pharmaceuticals and Galapagos go up and down completely randomly.

Pair Corralation between Polydex Pharmaceuticals and Galapagos

Assuming the 90 days horizon Polydex Pharmaceuticals is expected to generate 1.35 times more return on investment than Galapagos. However, Polydex Pharmaceuticals is 1.35 times more volatile than Galapagos NV ADR. It trades about 0.04 of its potential returns per unit of risk. Galapagos NV ADR is currently generating about -0.07 per unit of risk. If you would invest  190.00  in Polydex Pharmaceuticals on January 25, 2024 and sell it today you would earn a total of  9.00  from holding Polydex Pharmaceuticals or generate 4.74% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy27.94%
ValuesDaily Returns

Polydex Pharmaceuticals  vs.  Galapagos NV ADR

 Performance 
       Timeline  
Polydex Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Polydex Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Polydex Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders.
Galapagos NV ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Galapagos NV ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in May 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Polydex Pharmaceuticals and Galapagos Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Polydex Pharmaceuticals and Galapagos

The main advantage of trading using opposite Polydex Pharmaceuticals and Galapagos positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Polydex Pharmaceuticals position performs unexpectedly, Galapagos can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Galapagos will offset losses from the drop in Galapagos' long position.
The idea behind Polydex Pharmaceuticals and Galapagos NV ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios